Elicit Review 2026: Features, Pricing, Pros & Cons
Elicit searches more than 138 million academic papers and ClinicalTrials.gov records and structures evidence into search, screening, extraction and reporting steps. In May 2026 its Systematic Review workflow added PRISMA 2020 support, dual review and auditable exclusion or extraction decisions. In July the API and MCP exposed search, reports and systematic-review building blocks to external agents and pipelines. Retracted papers are excluded by default in the API description.
Open official website01Current product and version
Version checkedPRISMA 2020 systematic reviews, API and MCP, July 2026
Evidence-synthesis teams in biomedicine, policy and research who need an inspectable workflow rather than citations appended to a generic chatbot answer.
Elicit ranks fourth because its factored process aligns better with real systematic review than general AI search. The three DeepMind tools rank higher for frontier scientific impact, not because they are substitutes for literature review.
Elicit's reported recall and extraction performance comes from its own evaluation and specific benchmarks. Search strategies, bias assessment, duplicate screening and domain interpretation still require trained reviewers.
How this review was researched: This is a research-based review, not a claim of a private laboratory test. We checked current official product pages, documentation, release notes and pricing or plan information where available, then assessed workflow fit, maturity, access, control and implementation risk.
02Where it performs well
End-to-end search, screening, extraction and reporting workflow.
PRISMA 2020 support improves traceability and reproducibility.
API and MCP integrate evidence into research pipelines.
Decision exports and attached evidence support human audit.
03Limitations and risks
Vendor benchmarks may not generalize to a new discipline.
Database coverage and full-text access are never universal.
Automation can scale a flawed protocol or extraction rule.
Advanced systematic-review and API features require paid plans.
04Pricing and access
Elicit has individual Pro and higher Scale or Enterprise routes, with systematic-review volume and API access differing by plan. Price the number of concurrent reviews, papers screened, full-text retrieval, reviewers, API jobs and support; confirm current limits at purchase.
05Who should choose it
Choose Elicit when the team can define a protocol and inspect each step. Run a gold-standard pilot, preserve complete search strings and dates and independently verify included studies and critical extracted fields.
Alternatives to compare
Consensus for fast evidence-grounded questions and library work; Covidence for established review management; Rayyan for screening; PubMed and domain databases for reproducible source searching.
06A practical test before you commit
- 1
Define one real job
Use a task that reflects your actual team, data and output requirements.
- 2
Verify the access path
Confirm plan eligibility, regional availability, limits and required integrations.
- 3
Stress the main caveat
Test the limitation highlighted above with an edge case, not only a polished demo.
- 4
Compare one alternative
Run the same task in a credible alternative and record quality, time and total cost.
07Frequently asked questions
Does Elicit support PRISMA 2020?
Its May 2026 systematic-review release added workflows intended to support PRISMA 2020 traceability, including decisions and exports. Researchers still own protocol compliance.
How large is Elicit's search corpus?
The July 2026 API announcement states more than 138 million academic papers plus ClinicalTrials.gov records. Coverage and full text vary.
08Official sources checked
Primary documentation checked for this review. Product status and prices can change.
Elicit ranks fourth because its factored process aligns better with real systematic review than general AI search. The three DeepMind tools rank higher for frontier scientific impact, not because they are substitutes for literature review.